Business Wire - Janssen’s Risperdal Surpasses Conventional Therapies As No. 1 Prescribed Antipsychotic
Tuesday, December 23rd, 2008TITUSVILLE, N.J.–(BUSINESS WIRE)–Oct. 1, 1996–Risperdal(R) (risperidone), the drug therapy introduced by Janssen Pharmaceutica in 1994 for the management of psychotic disorders, has become the most often prescribed antipsychotic, capturing 20.7 percent of the market, the company announced today. New prescriptions written for Risperdal surpassed those…
